Compare Maravai LifeSciences Holdings Inc. Class A Common Stock (MRVI) vs PepsiCo, Inc. (PEP) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
Maravai LifeSciences Holdings Inc. Class A Common Stock vs PepsiCo, Inc. — how do they compare? Maravai LifeSciences Holdings Inc. Class A Common Stock trades at $6.56 (market cap $972.90M), while PepsiCo, Inc. trades at $130.95 (market cap $173.48B). The key difference: PepsiCo, Inc. is far larger — about 178.3× Maravai LifeSciences Holdings Inc. Class A Common Stock's market cap, and PepsiCo, Inc. pays a 4.65% dividend while Maravai LifeSciences Holdings Inc. Class A Common Stock pays none. Which is the better fit depends on your goals — on Pluang, investors hold Maravai LifeSciences Holdings Inc. Class A Common Stock for 0 Days and PepsiCo, Inc. for 108 Days on average.
| MRVI | PEP | |
|---|---|---|
Market Cap | $972.90M | $173.48B |
Volume | 4,325,710 | 11,774,872 |
Sector | Health | Consumer Staples |
52-Week High | $9.00 | $170.44 |
52-Week Low | $2.83 | $123.64 |
Typical Hold Time | 0 Days | 108 Days |
Enterprise Value | $1.08B | $214.19B |
Dividend Yield | — | 4.65% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Maravai LifeSciences (MRVI) trades at $6.53, down 7.51% in the last session amid mixed signals. The stock shows improving fundamentals with Q2 2026 revenue growth of 9% and three consecutive earnings beats, though it remains unprofitable with a -37.07% net margin. Technical analysis indicates neutral positioning with key support at $6 and resistance at $7. Recent news highlights patent expansions in China and institutional accumulation.
The outlook remains cautiously optimistic with analyst consensus pointing to 7% upside potential to the $7.00 price target. Key opportunities include margin expansion and RNA technology leadership, while risks center on persistent cash burn and competitive pressures in life sciences. The stock offers speculative growth potential for risk-tolerant investors.
PepsiCo (PEP) trades at $127.28, up 0.44% today, with a bearish technical signal but strong fundamentals including four consecutive quarterly EPS beats. The stock shows a P/E of 16.01 and a net income margin of 11.09%, supported by robust cash flow from operations of $12.09B in 2025. Recent news highlights price adjustments for snacks like Doritos to address consumer pushback on high prices.
The outlook is cautiously optimistic with a consensus price target of $142.38 implying 12% upside, though technical indicators suggest near-term resistance. Risks include competitive pressures and sensitivity to consumer spending trends, but the company's consistent profitability and dividend payments provide stability.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Investor sentiment on Pluang
What Pluang investors did over the last 30 days
Top news
Latest headlines on both assets
Top news
Latest headlines on both assets
About Maravai LifeSciences Holdings Inc. Class A Common Stock
Maravai LifeSciences Holdings Inc. is a life sciences company supporting drug therapy, diagnostic, and vaccine development through four operating brands: TriLink BioTechnologies (nucleic acid and mRNA synthesis), Cygnus Technologies (biologics safety testing), Glen Research (oligonucleotide synthesis materials), and Alphazyme (enzyme manufacturing). It serves biotech and biopharma customers from discovery through commercial manufacturing.
Read more on MRVI →About PepsiCo, Inc.
PepsiCo is one of the largest food and beverage companies globally. It makes, markets, and sells a slew of brands across the beverage and snack categories, including Pepsi, Mountain Dew, Gatorade, Doritos, Lays, and Ruffles. The firm uses a largely integrated go-to-market model, though it does leverage third-party bottlers, contract manufacturers, and distributors in certain markets. In addition to company-owned trademarks, Pepsi manufactures and distributes other brands through partnerships and joint ventures with companies such as Starbucks. The firm segments its operations into five primary geographies, with North America (comprising Frito-Lay North America, Quaker Foods North America, and North America beverages) constituting around 60% of consolidated revenue.
Read more on PEP →
